Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

UNC-0638 in combination with HRI knockdown leads to induction of fetal hemoglobin

Dec. 31, 2019

CTI BioPharma presents data from dose-finding PAC203 study of pacritinib

Dec. 31, 2019

Oral compound ameliorates beta-thalassemia

Dec. 30, 2019

Interim data from gene therapy trial confirm BCL11A as therapeutic target in SCD

Dec. 24, 2019

Freeline Therapeutics describes novel next-generation AAV-hFVIII vector candidate

Dec. 23, 2019

Novel mouse models of chronic sustained hypoxia and chronic intermittent hypoxia

Dec. 23, 2019

Sangamo Therapeutics presents preliminary data from phase I/II study of ST-400

Dec. 19, 2019

Hyper-sialylated IgG product M-254 well tolerated in healthy subjects in first-in-human trial

Dec. 18, 2019

Pharmacokinetic and antidrug antibody status of ABP-959 biosimilar compared to eculizumab

Dec. 17, 2019

Sanofi presents data from phase I repeat-dosing study of BIVV-001

Dec. 17, 2019

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...